Wahl, A. S.
Büchler, U.
Brändli, A.
Brattoli, B.
Musall, S.
Kasper, H.
Ineichen, B. V.
Helmchen, F.
Ommer, B.
Schwab, M. E.
Article History
Received: 28 September 2016
Accepted: 17 August 2017
First Online: 30 October 2017
Competing interests
: The University of Zurich holds joint patents with Novartis Pharma for antibodies against Nogo-A and their use in neurological diseases. M.E.S. is a board member of the spin-off company NovaGo Therapeutics Inc. The remaining authors declare no competing financial interests.